District | Drug packages | Coverage | Â | Â | |||
---|---|---|---|---|---|---|---|
Reported | Survey | Â | Â | ||||
Treated | Therapeutic coverage (%)a | Programme coverage (%)b | Median (%) | n | 95 % CI | ||
Kamuli | ZIT | 396,700 | 61 | 63 | 36.73c | 1078 | 33.85–39.61 |
 | IVM + ALB | 508,573 | 78 | 97 | 52.71c | 1089 | 49.73–55.67 |
 | PZQ | 29,470 | 75 | 94 | 57.39c | 1089 | 54.45–60.33 |
Mayuge | ZIT | 182,763 | 44 | 46 | 13.07c | 1094 | 11.07–15.07 |
 | PZQ + ALB | 37,666 | 28 | 35 | 36.42 | 1102 | 32.43–40.42 |
Yumbe | IVM + ALB | 295,179 | 74 | 93 | 72.76 | 984 | 69.97–75.55 |
 | PZQ | 278,670 | 70 | 88 | 77.16c | 972 | 74.51–79.80 |
Pallisa | IVM + ALB | 386,859 | 92 | 96 | 62.59c | 1096 | 59.72–65.46 |